Based on ACR recommendations, allopurinol is strongly recommended as a first-line urate-lowering medication. Genetic screening is suggested (for any variant referred to as HLA B*5801) ahead of setting up allopurinol as the carriers of this gene are at an elevated chance of the significant allergic r